🔮 Better than the Oracle? Our Fair Value found this +42% bagger 5 months before Buffett bought itRead More

MKS Instruments Analysts Await Elaboration On Ransomware Impact Post Q4 Results

Published 28/02/2023, 19:32
© Reuters.  MKS Instruments Analysts Await Elaboration On Ransomware Impact Post Q4 Results
MKSI
-

Benzinga -

  • Benchmark analyst Mark Miller had a Hold rating on MKS Instruments, Inc (NASDAQ: MKSI).
  • For its 4Q22, MKS reported adjusted EPS of $2.00 on record quarterly sales of $1.09 billion.
  • These results include a full quarter of the Atotech acquisition.
  • The consensus estimate for MKS’s 4Q22 called for adjusted EPS of $1.34 per diluted share on sales of $994 million.
  • MKS reported a quarterly cash flow from operations of $184 million and a free cash flow of $130 million, enabling a $100 million voluntary term loan prepayment in December.
  • The company anticipates the previously announced ransomware incident identified on February 3 to have a material impact on the company’s Q1 results.
  • MKS is yet to determine the full scope of the costs and related impacts of the incident.
  • As a result, the company will not provide its usual Q1 guidance at this time.
  • The company currently estimates the impact of the incident on Q1 revenue to be at least $200 million.
  • MKS expects to resume its normal guidance practice for Q2.
  • Commentary indicated results were driven by “solid operational execution,” though KeyBanc analyst Steve Barger expected comments surrounding segment performance on Wednesday’s call given the communicated softness in Semiconductor and Electronics & Packaging (previously Advanced Electronics).
  • The analyst expects to hear more detail about the ransomware event, commentary surrounding 2023, end markets, ATC contribution, and expected margin progression on Wednesday’s call.
  • Price Action: MKSI shares traded higher by 7.20% at $98.82 on the last check Tuesday.
Latest Ratings for MKSI DateFirmActionFromTo
Feb 2022Loop CapitalInitiates Coverage OnBuy
Jan 2022Deutsche BankMaintainsBuy
Jan 2022RosenblattMaintainsBuy
View More Analyst Ratings for MKSI

View the Latest Analyst Ratings

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.